US Stock MarketDetailed Quotes

BOLT Bolt Biotherapeutics

Watchlist
  • 0.735
  • -0.004-0.51%
Trading Jul 12 10:02 ET
28.03MMarket Cap-442P/E (TTM)

Bolt Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
188.83%5.27M
37.48%7.88M
48.05%2.09M
19.70%2.53M
2.87%1.43M
124.60%1.83M
354.68%5.73M
177.76%1.41M
180.85%2.11M
1.39M
Operating revenue
188.83%5.27M
37.48%7.88M
48.05%2.09M
19.70%2.53M
2.87%1.43M
124.60%1.83M
354.68%5.73M
177.76%1.41M
180.85%2.11M
--1.39M
Cost of revenue
Gross profit
Operating expense
10.50%22.37M
-12.47%84.07M
-2.65%21.86M
-15.32%20.71M
-13.03%21.27M
-18.02%20.24M
2.13%96.05M
-18.61%22.45M
0.74%24.46M
2.91%24.45M
Selling and administrative expenses
3.94%5.84M
-1.73%22.53M
-1.30%5.53M
5.01%5.76M
1.61%5.62M
-10.91%5.62M
24.65%22.93M
9.94%5.61M
11.01%5.49M
36.46%5.53M
-General and administrative expense
3.94%5.84M
-1.73%22.53M
-1.30%5.53M
5.01%5.76M
1.61%5.62M
-10.91%5.62M
24.65%22.93M
9.94%5.61M
11.01%5.49M
36.46%5.53M
Research and development costs
13.02%16.53M
-15.84%61.54M
-3.10%16.32M
-21.20%14.95M
-17.32%15.64M
-20.45%14.63M
-3.35%73.12M
-25.08%16.85M
-1.88%18.97M
-3.99%18.92M
Operating profit
7.18%-17.09M
15.64%-76.2M
6.06%-19.77M
18.63%-18.18M
13.99%-19.83M
22.87%-18.42M
2.66%-90.32M
22.29%-21.04M
5.02%-22.35M
2.95%-23.06M
Net non-operating interest income expense
11.92%1.61M
214.84%7M
78.62%1.86M
228.11%1.93M
349.37%1.78M
624.75%1.44M
691.10%2.22M
1,371.95%1.04M
348.09%587K
124.43%395K
Non-operating interest income
11.92%1.61M
214.84%7M
78.62%1.86M
228.11%1.93M
349.37%1.78M
624.75%1.44M
691.10%2.22M
1,371.95%1.04M
348.09%587K
124.43%395K
Other net income (expense)
4.68M
Other non- operating income (expenses)
--4.68M
----
----
----
----
----
----
----
----
----
Income before tax
36.33%-10.81M
21.45%-69.2M
10.47%-17.9M
25.29%-16.26M
20.33%-18.06M
28.29%-16.98M
10.64%-88.1M
26.37%-20M
6.99%-21.76M
3.91%-22.66M
Income tax
Net income
36.33%-10.81M
21.45%-69.2M
10.47%-17.9M
25.29%-16.26M
20.33%-18.06M
28.29%-16.98M
10.64%-88.1M
26.37%-20M
6.99%-21.76M
3.91%-22.66M
Net income continuous Operations
36.33%-10.81M
21.45%-69.2M
10.47%-17.9M
25.29%-16.26M
20.33%-18.06M
28.29%-16.98M
10.64%-88.1M
26.37%-20M
6.99%-21.76M
3.91%-22.66M
Minority interest income
Net income attributable to the parent company
36.33%-10.81M
21.45%-69.2M
10.47%-17.9M
25.29%-16.26M
20.33%-18.06M
28.29%-16.98M
10.64%-88.1M
26.37%-20M
6.99%-21.76M
3.91%-22.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
36.33%-10.81M
21.45%-69.2M
10.47%-17.9M
25.29%-16.26M
20.33%-18.06M
28.29%-16.98M
10.64%-88.1M
26.37%-20M
6.99%-21.76M
3.91%-22.66M
Basic earnings per share
37.78%-0.28
22.46%-1.83
11.32%-0.47
25.86%-0.43
21.31%-0.48
29.69%-0.45
20.54%-2.36
27.40%-0.53
7.94%-0.58
4.69%-0.61
Diluted earnings per share
37.78%-0.28
22.46%-1.83
11.32%-0.47
25.86%-0.43
21.31%-0.48
29.69%-0.45
20.54%-2.36
27.40%-0.53
7.94%-0.58
4.69%-0.61
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 188.83%5.27M37.48%7.88M48.05%2.09M19.70%2.53M2.87%1.43M124.60%1.83M354.68%5.73M177.76%1.41M180.85%2.11M1.39M
Operating revenue 188.83%5.27M37.48%7.88M48.05%2.09M19.70%2.53M2.87%1.43M124.60%1.83M354.68%5.73M177.76%1.41M180.85%2.11M--1.39M
Cost of revenue
Gross profit
Operating expense 10.50%22.37M-12.47%84.07M-2.65%21.86M-15.32%20.71M-13.03%21.27M-18.02%20.24M2.13%96.05M-18.61%22.45M0.74%24.46M2.91%24.45M
Selling and administrative expenses 3.94%5.84M-1.73%22.53M-1.30%5.53M5.01%5.76M1.61%5.62M-10.91%5.62M24.65%22.93M9.94%5.61M11.01%5.49M36.46%5.53M
-General and administrative expense 3.94%5.84M-1.73%22.53M-1.30%5.53M5.01%5.76M1.61%5.62M-10.91%5.62M24.65%22.93M9.94%5.61M11.01%5.49M36.46%5.53M
Research and development costs 13.02%16.53M-15.84%61.54M-3.10%16.32M-21.20%14.95M-17.32%15.64M-20.45%14.63M-3.35%73.12M-25.08%16.85M-1.88%18.97M-3.99%18.92M
Operating profit 7.18%-17.09M15.64%-76.2M6.06%-19.77M18.63%-18.18M13.99%-19.83M22.87%-18.42M2.66%-90.32M22.29%-21.04M5.02%-22.35M2.95%-23.06M
Net non-operating interest income expense 11.92%1.61M214.84%7M78.62%1.86M228.11%1.93M349.37%1.78M624.75%1.44M691.10%2.22M1,371.95%1.04M348.09%587K124.43%395K
Non-operating interest income 11.92%1.61M214.84%7M78.62%1.86M228.11%1.93M349.37%1.78M624.75%1.44M691.10%2.22M1,371.95%1.04M348.09%587K124.43%395K
Other net income (expense) 4.68M
Other non- operating income (expenses) --4.68M------------------------------------
Income before tax 36.33%-10.81M21.45%-69.2M10.47%-17.9M25.29%-16.26M20.33%-18.06M28.29%-16.98M10.64%-88.1M26.37%-20M6.99%-21.76M3.91%-22.66M
Income tax
Net income 36.33%-10.81M21.45%-69.2M10.47%-17.9M25.29%-16.26M20.33%-18.06M28.29%-16.98M10.64%-88.1M26.37%-20M6.99%-21.76M3.91%-22.66M
Net income continuous Operations 36.33%-10.81M21.45%-69.2M10.47%-17.9M25.29%-16.26M20.33%-18.06M28.29%-16.98M10.64%-88.1M26.37%-20M6.99%-21.76M3.91%-22.66M
Minority interest income
Net income attributable to the parent company 36.33%-10.81M21.45%-69.2M10.47%-17.9M25.29%-16.26M20.33%-18.06M28.29%-16.98M10.64%-88.1M26.37%-20M6.99%-21.76M3.91%-22.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 36.33%-10.81M21.45%-69.2M10.47%-17.9M25.29%-16.26M20.33%-18.06M28.29%-16.98M10.64%-88.1M26.37%-20M6.99%-21.76M3.91%-22.66M
Basic earnings per share 37.78%-0.2822.46%-1.8311.32%-0.4725.86%-0.4321.31%-0.4829.69%-0.4520.54%-2.3627.40%-0.537.94%-0.584.69%-0.61
Diluted earnings per share 37.78%-0.2822.46%-1.8311.32%-0.4725.86%-0.4321.31%-0.4829.69%-0.4520.54%-2.3627.40%-0.537.94%-0.584.69%-0.61
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg